(Q38084195)

28 August 2017

title

Linaclotide, novel therapy for the treatment of chronic idiopathic constipation and constipation-predominant irritable bowel syndrome (English)

1 reference

28 August 2017

1 reference

Maria I Vazquez-Roque

series ordinal

1

1 reference

28 August 2017

Ernest P Bouras

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

20 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

30

1 reference

28 August 2017

issue

3

1 reference

28 August 2017

page(s)

203-211

1 reference

Epidemiology of constipation in North America: a systematic review

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Cumulative incidence of chronic constipation: a population-based study 1988-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

A longitudinal survey of self-reported bowel habits in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Physician visits in the United States for constipation: 1958 to 1986.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: an analysis of the National Health and Wellness Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

The burden of IBS: looking at metrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

A placebo-controlled trial of prucalopride for severe chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Pilot study on the effect of linaclotide in patients with chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Efficacy of linaclotide for patients with chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Two randomized trials of linaclotide for chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0012-9

10.1007/S12325-013-0012-9

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1001836714

0 references

1 reference